Supriya Lifescience Limited

₹650.95As of Sun 8 Nov 2026, 12:00 UTC
NSE:SUPRIYAHealthcare
Country India
PE (Fwd) •••
TSR 5Y CAGR 6.48%
Div yield 0.15%
ROE 15.25%
Biotechnology
Beta (5Y) 0.67
PE TTM 29.58
TSR TTM (16.11%)
Mkt cap ₹52.39B
ROIC 14.89%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹819
25.84%
(62.51%)
Sell 0|5|11|4|8
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
9.53
10.07
10.77
10.39
18.41%
20.58%
34.21%
17.41%
Revenue₹B
4.619
4.681
4.917
4.950
6.34%
6.94%
9.97%
8.01%
Peers (US$596.2M)
Cap (US$)
PE
1.124B
34.63x
595.5M
—
Capital
TTM
5Y
10Y
Leveragex
1.109
0.180
0.173
EBIT/Intx
5.580
0.080
0.086
Own earn%
(426.84)
61.77
66.42
Sh yield%
30.83
43.86
43.87
Owners
Insiders/Inst%
6.96
43.97
Short interest%
3.51
SBC / revenue%
5.02
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
13–23
$1 testx
—
Incr. ROIC%
10